Medopia
6095.TTSE PRIME
Filed as MedPeer, Inc. (2022-08–2025-05)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| NMT, Inc.joint holder | 62.15% |
| Iwami Yo | 23.82% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 3
| BOZO, inc. | 0.00% |
| Natsuko Iwami | 0.00% |
| Maki Hiroyuki | 0.00% |
Ownership history · 29
| Holder | Ratio | Change |
|---|---|---|
| BOZO, inc.2025-10-10 | 0.00% | -5.68pp |
| Iwami Yo2025-10-10 | 23.82% | +5.32pp |
| NMT, Inc.2025-10-10joint | 62.15% | no change |
| BOZO, inc.2025-08-29 · amended | 5.68% | no change |
| Iwami Yo2025-08-29 · amended | 18.50% | no change |
| NMT, Inc.2025-08-29 · amendedjoint | 62.15% | no change |
| Natsuko Iwami2025-08-15 | 0.00% | new |
| BOZO, Inc.2025-08-15 | 5.68% | no change |
| Yo Iwami2025-08-15 | 18.50% | no change |
| NMT, Inc.2025-08-15joint | 62.15% | no change |
| BOZO2025-08-15joint | 5.68% | new |
| Iwami Yo2025-08-15joint | 18.50% | new |
| NMT, Inc.2025-08-15 | 62.15% | new |
| Maki Hiroyuki2025-05-21 · amended | 0.00% | -27.84pp |
| Maki Hiroyuki2025-05-21 · amended | 27.84% | no change |
| Maki Hiroyuki2025-05-21 · amended | 27.84% | +0.97pp |
| Maki Hiroyuki2025-05-21 · amended | 26.87% | +1.20pp |
| Maki Hiroyuki2025-05-21 · amended | 25.67% | +1.37pp |
| Maki Hiroyuki2025-05-21 · amended | 24.30% | +3.42pp |
| Maki Hiroyuki2025-05-21 · amended | 20.88% | +1.53pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.